Trials / Sponsors / SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in C Healthy | Phase 1 | 2021-12-25 |
| Completed | Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Hemorrhage, Urgent Surgery, Invasive Procedure | Phase 3 | 2020-07-15 |
| Completed | Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50- Healthy | Phase 2 | 2019-09-24 |
| Completed | Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects Healthy | Phase 2 | 2019-04-16 |
| Completed | Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers Healthy | Phase 1 | 2018-04-03 |